What is Cushing's syndrome? Cushing's syndrome is a hormonal disorder. It’s caused when you have high levels of the hormone cortisol over a long time. Cushing's syndrome is fairly rare. It most often ...

With an FDA approval submission for RegenXBio’s Hunter syndrome gene therapy already underway, the biopharma has now found a commercialization partner for both the U.S. and Asian markets.

The partnership will focus on advancing RGX-121 as a treatment for mucopolysaccharidosis II (MPS II), also known as Hunter syndrome, and RGX-111 for treating mucopolysaccharidosis I (MPS I), also ...

Denali’s wholly owned program, DNL310 or tividenofusp alfa, is an Enzyme Transport Vehicle-enabled iduronate-2-sulfatase (IDS) replacement therapy in development for MPS II (Hunter syndrome).

Hunter syndrome affects over 2,000 individuals, primarily males, in commercially accessible regions. With analysts maintaining a Strong Buy consensus and the company maintaining a healthy liquidity ...

Romania seems poised to become a bigger tourist attraction in 2025 after being recommended as a stellar destination by Vogue and CNN. Both publications signal that their choice for Romania was ...

Bulgaria and Romania rang in the new year with full entry to the European Union’s passport-free Schengen area, promising a fresh boost to their economies. The lifting of controls at land borders ...

Romania and Bulgaria have become full members of the Schengen zone, expanding the borderless area to 29 members and ending a 13-year wait for the two Eastern European countries. The expansion ...